WHO - World Health Organization
Antiretroviral therapy for HIV infection in infants and children : towards universal access : recommendations for a public health approach / WHO - Worl Health Organization - iv, 144 p. : tablas ; 24 x 16 cm. - HIV/AIDS Programme : Strengthening health services to fight HIV/AIDS .
Objetives of the guidelines -- Development of the guidelines -- Establishing diagnosis of HIV infection - When to Start Antiretroviral Therapy in Infants and Children -- What to Start - Recommended first-Line ARV Regimens in Infants and Children -- Considerations for ART in Infants Previously Exposed to ARV Drugs Atiretroviral drug Toxicity -- Substituting whithin a First-line ARV Regimen in Infants and CHILDREN because of Drug Toxicity -- Sitching an ARV Regimen in Infants and Children. Treatment Failure -- Choise of ARV Regimens in the Event of Treatment Failure of First-Line Regimens in Infants and Children - Second-Line Regimens -- Considerations for infants and children Coinfected With Tuberculosis and HIV -- Considerations for Nutrition in HIV-infected Infants and Children -- Considerations for ART in Adolescents -- Clinical and Laboratory Monitoring -- Adherence to ART -- Strategies in the Event of Failure of Second-Line Regimens -- Drug Resistance -- Members of the technical reference group on paediatric HIV care and treatment -- WHO clinical staging of HIV for infants and children with established HIV infection -- Presumptive and definitive criteria for recognizing HIV related clinical events in infants and children with established HIV infection -- WHO classification of HIV-associated immunodeficency in infants and children -- 12 Month mortality risk at selected thresholds for %CD4+, absolute CD4 count and total lymphocyte count by age -- Prescribing information and weight based dosing of available ARV formulations for infants and children -- Seroius acute and chronic toxicities caused by ARV drugs, possibly requiring therapy modification: clinical preenation, laboratory abnormalities and implications for ART management -- Severity grading of selected clinical and laboratory toxicities most commonly seen with recommended ARV drugs for children -- Sexual maturity rating (Tanner staging) in adolescents -- Recommended tiered laboratory capabilities for ART monitoring in resource-limited s settings -- References --
92 4 159469 1 -- 978 92 4 159469 1
Agentes antiretrovirales--farmacología
Agentes antiretrovirales--terapéutica
Farmacologia y terapeutica
Medicina
Infecciones del vih--terapia de droga
Terapia antiretroviral
Terapia antiretroviral altamente activa
Terapias
Salud
615.85 / W551a
Antiretroviral therapy for HIV infection in infants and children : towards universal access : recommendations for a public health approach / WHO - Worl Health Organization - iv, 144 p. : tablas ; 24 x 16 cm. - HIV/AIDS Programme : Strengthening health services to fight HIV/AIDS .
Objetives of the guidelines -- Development of the guidelines -- Establishing diagnosis of HIV infection - When to Start Antiretroviral Therapy in Infants and Children -- What to Start - Recommended first-Line ARV Regimens in Infants and Children -- Considerations for ART in Infants Previously Exposed to ARV Drugs Atiretroviral drug Toxicity -- Substituting whithin a First-line ARV Regimen in Infants and CHILDREN because of Drug Toxicity -- Sitching an ARV Regimen in Infants and Children. Treatment Failure -- Choise of ARV Regimens in the Event of Treatment Failure of First-Line Regimens in Infants and Children - Second-Line Regimens -- Considerations for infants and children Coinfected With Tuberculosis and HIV -- Considerations for Nutrition in HIV-infected Infants and Children -- Considerations for ART in Adolescents -- Clinical and Laboratory Monitoring -- Adherence to ART -- Strategies in the Event of Failure of Second-Line Regimens -- Drug Resistance -- Members of the technical reference group on paediatric HIV care and treatment -- WHO clinical staging of HIV for infants and children with established HIV infection -- Presumptive and definitive criteria for recognizing HIV related clinical events in infants and children with established HIV infection -- WHO classification of HIV-associated immunodeficency in infants and children -- 12 Month mortality risk at selected thresholds for %CD4+, absolute CD4 count and total lymphocyte count by age -- Prescribing information and weight based dosing of available ARV formulations for infants and children -- Seroius acute and chronic toxicities caused by ARV drugs, possibly requiring therapy modification: clinical preenation, laboratory abnormalities and implications for ART management -- Severity grading of selected clinical and laboratory toxicities most commonly seen with recommended ARV drugs for children -- Sexual maturity rating (Tanner staging) in adolescents -- Recommended tiered laboratory capabilities for ART monitoring in resource-limited s settings -- References --
92 4 159469 1 -- 978 92 4 159469 1
Agentes antiretrovirales--farmacología
Agentes antiretrovirales--terapéutica
Farmacologia y terapeutica
Medicina
Infecciones del vih--terapia de droga
Terapia antiretroviral
Terapia antiretroviral altamente activa
Terapias
Salud
615.85 / W551a